Retension Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2025-12-31 |
|---|---|---|
Cash | 13,493 | 18,901 |
Basic Shares | 8,331 | 8,331 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -6,880 | -2,281 |
EBIT | -6,880 | -2,281 |
Net Income | -6,301 | -1,909 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -7,780 | -1,755 |
Cash | 18,901 | 8,185 |
Basic Shares | 8,331 | 8,331 |